A Review of Immune-Mediated Adverse Events in Melanoma
Abstract The use of checkpoint inhibitor-based immunotherapy has transformed the treatment landscape for melanoma as well as many other cancer types. With the ability to potentiate tumor-specific immune responses, these agents can result in durable tumor control. However, this activation of the immu...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Adis, Springer Healthcare
2019-07-01
|
| Saila: | Oncology and Therapy |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1007/s40487-019-0096-8 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|